-transparent.png){kind=logo}
Structural modification of the cardiotonic agent, loprinone (E-1020, 1), suggested by data that it has a less positive chronotropic effect than milrinone (15), led us to find novel bradycardic agents that were structurally different from homoveratryl amine derivatives. Alkyl-oxy, -thio, and -amino derivatives at the 2-position of the pyridine ring of 1 produced bradycardic activity without a significant effect on blood pressure and myocardial contractility. Aryloxy analogues also decreased heart rate, and members with an electron-withdrawing group at the ortho position of the phenyl ring showed higher activity. Replacement of the imidazo[1,2-alpha]pyridine with pyridine resulted in diminished activity. The mechanism of bradycardic activity of these compounds seems to be direct action on the sinus node.
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
January 2008,
Bioorganic & medicinal chemistry,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
April 2016,
The Journal of organic chemistry,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
September 2016,
Steroids,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
June 2010,
Acta chimica Slovenica,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
February 1990,
Journal of medicinal chemistry,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
June 2003,
The Journal of organic chemistry,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
November 2011,
Acta crystallographica. Section E, Structure reports online,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
January 2009,
Acta poloniae pharmaceutica,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
March 2013,
Bioorganic & medicinal chemistry letters,
M Yamanaka, and
S Suda, and
Y Kabasawa, and
T Kawamura, and
T Ogawa, and
K Sawada, and
H Ohhara
April 2003,
Organic letters,
